| 臺大學術典藏 |
2021-06-04T06:23:01Z |
Aspirin modifies inflammatory mediators and metabolomic profiles and contributes to the suppression of obesity-associated breast cancer cell growth
|
Hsieh C.-C.; Chiu H.-H.; Wang C.-H.; CHING-HUA KUO |
| 臺大學術典藏 |
2021-11-17T08:07:01Z |
Aspirin modifies inflammatory mediators and metabolomic profiles and contributes to the suppression of obesity-associated breast cancer cell growth
|
Hsieh CC; Chiu HH; Wang CH; Kuo CH |
| 臺大學術典藏 |
2021-11-17T08:13:40Z |
Aspirin modifies obesity-related metabolomic profiles and suppresses breast cancer cell growth
|
Hsieh CC; Wang CH |
| 輔英科技大學 |
2023-03-18 |
Aspirin modulates N6 methyladenosine RNA modification in primary effusion lymphoma cells
|
徐慧雯 |
| 輔英科技大學 |
2023-03-18 |
Aspirin modulates N6 methyladenosine RNA modification in primary effusion lymphoma cells
|
王怡棻 |
| 臺北醫學大學 |
2015-12 |
Aspirin phamacology
|
簡敬倫 |
| 中國醫藥大學 |
2013-07 |
Aspirin protects human coronary artery endothelial cells against atherogenic electronegative LDL via an epigenetic mechanism: A novel cytoprotective role of aspirin in acute myocardial infarction
|
(Po-Yuan Chang);(Yi-Jie Chen);(Fu-Hsiung Chang);(Jonathan Lu);(Wen-Huei Huang);(Tzu-Ching Yang);(Yuan-Teh Lee);(Shwu-Fen Chang);(Shao-Chun Lu);陳珠璜(Chu-Huang Chen)* |
| 臺大學術典藏 |
2020-01-21T06:05:54Z |
Aspirin protects human coronary artery endothelial cells against atherogenic electronegative LDL via an epigenetic mechanism: A novel cytoprotective role of aspirin in acute myocardial infarction
|
Lee Y.-T.; Chang S.-F.; Lu S.-C.; Chen C.-H.; Chang P.-Y.; Chen Y.-J.; FU-HSIUNG CHANG; Lu J.; Huang W.-H.; Yang T.-C. |
| 臺大學術典藏 |
2020-02-06T08:11:27Z |
Aspirin protects human coronary artery endothelial cells against atherogenic electronegative LDL via an epigenetic mechanism: A novel cytoprotective role of aspirin in acute myocardial infarction
|
Chang P.-Y.;Chen Y.-J.;Chang F.-H.;Lu J.;Huang W.-H.;Yang T.-C.;Lee Y.-T.;Chang S.-F.;Shao-Chun Lu;Chen C.-H.; Chang P.-Y.; Chen Y.-J.; Chang F.-H.; Lu J.; Huang W.-H.; Yang T.-C.; Lee Y.-T.; Chang S.-F.; SHAO-CHUN LU; Chen C.-H. |
| 臺大學術典藏 |
2013 |
Aspirin protects human coronary artery endothelial cells against atherogenic electronegative LDL via an epigenetic mechanism: A novel cytoprotective role of aspirin in acute myocardial infarction
|
Yang T.-C.; Lu J.; Huang W.-H.; Chang F.-H.; Chen Y.-J.; PO-YUAN CHANG; Lee Y.-T.; Chang S.-F.; Lu S.-C.; Chen C.-H. |
| 國家衛生研究院 |
2009-05 |
Aspirin versus clopidogrel in combination with proton-pump inhibitors for prevention of recurrent peptic ulcer complications in patients with previous gastrointestinal bleeding
|
Hsiao, FY;Tsai, YW;Huang, WF;Wen, YW;Chen, PF;Chang, PY;Kuo, KN |
| 高雄醫學大學 |
2015 |
Aspirin 合併 cisplatin對人類泌尿上皮細胞癌及抗藥株的毒殺效果與機制探討
|
陳美晨; Chen, Mei-Chen |
| 中山醫學大學 |
2014 |
Aspirin-induced inhibition of adipogenesis was p53-dependent and associated with inactivation of pentose phosphate pathway.
|
Su YF; Yang, SH; Lee, YH; Wu, BC; Huang, SC; Liu, CM; Chen, SL; Pan, YF; Chou, SS; Chou, MY; Yang HW |
| 臺北醫學大學 |
1968-01 |
Aspirin之分解及其安定性
|
羅境鏜 |
| 臺北醫學大學 |
2000 |
Aspirin和Ticlopidine抑制人類臍帶內皮細胞所表現的 趨化激素 (單核球趨化激素-1、介白質素-8)
|
張素梅; Su-Mei Chang |
| 中國醫藥大學 |
1999-07-31 |
Aspirin對肝癌細胞株中乙醯轉移酵素活性的影響
|
吳禮字(Wu,Lii-Tzu); 鍾景光(教授,研) |
| 中山醫學大學 |
2002 |
Aspirin於p53及其標的與調節基因之作用機制探討
|
周明勇; Chou, Ming-Yung |
| 中山醫學大學 |
2002-08-01 |
Aspirin於p53及其標的與調節基因之作用機制探討
|
周明勇 |
| 國立臺灣大學 |
2008 |
Aspm (Abnormal Spindle-Like, Microcephaly-Associated) Gene Encoding a Centrosome Protein Is Involved in Cell Proliferation, Tumor Cell Invasion and Overexpressed in Hcc
|
潘弘偉; 林事曄; 周涵怡; 許輝吉; PAN, HUNG-WEI; LIN, SHIH-YEH; CHOU, HAN- YI; HSU, HEY-CHI |
| 國家衛生研究院 |
2023-01-13 |
ASPM activates Hedgehog and Wnt signaling to promote small cell lung cancer stemness and progression
|
Cheng, LH;Hsu, CC;Tsai, HW;Liao, WY;Yang, PM;Liao, TY;Hsieh, HY;Chan, TS;Tsai, KK |
| 國立成功大學 |
2023 |
ASPM Activates Hedgehog and Wnt Signaling to Promote Small Cell Lung Cancer Stemness and Progression
|
Cheng, L.-H.;Hsu, C.-C.;Tsai, H.-W.;Liao, W.-Y.;Yang, P.-M.;Liao, T.-Y.;Hsieh, Hsieh H.-Y.;Chan, T.-S.;Tsai, K.K. |
| 國立臺灣大學 |
2008 |
Aspm Is a Novel Marker for Vascular Invasion, Early Recurrence, and Poor Prognosis of Hepatocellular Carcinoma
|
林事曄; 潘弘偉; 柳書祥; 鄭永銘; 胡賦強; 彭向陽; 賴寶蓮; 許輝吉; LIN, SHIH-YEH; PAN, HUNG-WEI; LIU, SHU- HSIANG; JENG, YUNG-MING; HU, FU-CHANG; PENG, SHIAN-YANG; LAI, PO-LIN; HSU, HEY-CHI |
| 國立臺灣大學 |
2008-08 |
ASPM is a novel marker for vascular invasion, early recurrence, and poor prognosis of hepatocellular carcinoma.
|
Lin, SY; Pan, HW; Liu, SH; Jeng, YM; Hu, FC; Peng, SY; Lai, PL; Hsu, HC. |
| 國家衛生研究院 |
2018-09-28 |
ASPM promotes prostate cancer stemness and progression by augmenting Wnt-Dvl-3-beta-catenin signaling
|
Pai, VC;Hsu, CC;Chan, TS;Liao, WY;Chuu, CP;Chen, WY;Li, CR;Lin, CY;Hwang, SP;Chen, LT;Tsai, KK |
| 國家衛生研究院 |
2018-11-02 |
ASPM promotes prostate cancer stemness and progression by augmenting Wnt-Dvl-3-beta-catenin signaling [Erratum: Oncogene. 2018 Sep 28;Article in Press.]
|
Pai, VC;Hsu, CC;Chan, TS;Liao, WY;Chuu, CP;Chen, WY;Li, CR;Lin, CY;Huang, SP;Chen, LT;Tsai, KK |
